Cover of Cancer Conversations with CMCA

Cancer Conversations with CMCA

Cancer Conversations with CMCA

By: Cheshire and Merseyside Cancer Alliance
Listen for free

Season's Savings | 0.99 €/month for 3 months

5.99 €/month thereafter - terms apply. Cancel monthly.
Summary

Welcome to Cancer Conversations, a collaborative podcast series bringing together perspectives from Primary and Secondary Care to explore current and topical issues in cancer, focusing on difficult and challenging aspects of cancer care, and aimed at supporting and informing clinicians across healthcare and members of the public.

We are always trying to improve the educational resources we offer, and your feedback is vital in helping us shape our future planning. We would appreciate if you could spare a few minutes to complete this anonymous survey.
The Primary Care Cancer Team, Cheshire and Merseyside Cancer Alliance
Cancer Conversations with CMCA: Feedback Survey – Fill in form
Episodes
  • 4: Ep.4 HRT, Menopause and Breast Cancer

    4: Ep.4 HRT, Menopause and Breast Cancer
    1 Oct 2026
    In this episode, Dr Jennifer McBride (GP with a specialist interest in Sexual Medicine and Reproductive Health and Sefton GP Clinical Lead for Gynaecology at the Cheshire & Merseyside Cancer Alliance) joins Miss Sonia Bathla (Consultant Oncoplastic Breast Surgeon at the Burney Breast Unit, Mersey and West Lancashire Teaching Hospitals NHS Trust) to discuss how patients with menopausal symptoms commonly present in primary care, which symptoms matter most to them, and what clinical assessment is required. They clarify the relationship between HRT and breast cancer risk, including management options and when referral is appropriate. They also explore the challenges of managing treatment-related menopausal symptoms in women with breast cancer, including patient concerns, available treatment options, and contraceptive choices, including hormonal methods. Practical resources are included to support clinical practice and deepen listeners’ understanding. Here are the links to the resources mentioned in the episode:1. British Menopause Society. Fast Facts: HRT and Breast Cancer Risk (Sep 2025) https://thebms.org.uk/wp-content/uploads/2025/09/12-NEW-BMS-ToolsforClinicians-Fast-Facts-HRT-and-Beast-Cancer-Risk-SEPT2025-B.pdf 2. British Menopause Society Short videos on : HRT & Risk Of Breast Cancer, HRT & breast cancer: overall risks and benefits, Post Cancer Treatments https://thebms.org.uk/publications/bms-tv/ 3. Update on Menopause Hormone Therapy: Current Indications and Unanswered Questions. Mukherjee A, Davis SR. Clinical Endocrinology 2025. https://onlinelibrary.wiley.com/doi/10.1111/cen.15211?msockid=09b63fd088756a85080429af893b6bd7 4. British Menopause Society. Consensus statement: The benefits and risks of HRT before and after a breast cancer diagnosis. Updated September 2025. https://thebms.org.uk/publications/consensus-statements/risks-and-benefits-of-hrt-before-and-after-a-breast-cancer-diagnosis/ 5. NICE CG164, Familial Breast Cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer: Section 1.7.10 Hormone Replacement Therapy) https://www.nice.org.uk/guidance/cg164/chapter/Recommendations 6. British Menopause Society. Consensus statement: Management of oestrogen deficiency symptoms and arthralgia in women treated for early breast cancer. Updated September 2025. https://thebms.org.uk/wp-content/uploads/2025/09/03-BMS-ConsensusStatement-Management-of-symptoms-after-breast-cancer-SEPT2025-C.pdf 7. NICE NG23: Discussion aid - HRT and likelihood of some medical conditions (includes breast cancer) https://www.nice.org.uk/guidance/ng23/resources/incidence-of-medical-conditions-with-and-without-hrt-a-discussion-aid-pdf-13553199901 8. NICE NG101 – Early and locally advanced breast cancer: diagnosis and management, Section 1.14.20 – 25 Menopausal Symptoms. https://www.nice.org.uk/guidance/ng101/chapter/Recommendations#management-of-treatment-side-effects-and-menopausal-symptoms 9. British Menopause Society. BMS Tool for Clinicians: Prescribable alternatives to HRT: updated March 2026 https://thebms.org.uk/wp-content/uploads/2026/03/02-NEW-BMS-Prescribable-alternatives-to-HRT-MARCH2026-A.pdf 10. NICE: Clinical Knowledge Series: Menopause: Prescribing Information: Fezolinetant (May 2026) https://cks.nice.org.uk/topics/menopause/prescribing-information/fezolinetant/ 11. Contraception and Breast Cancer, FSRH Guidance: The College of Sexual & Reproductive Healthcare, 2023 https://www.cosrh.org/Public/Public/Standards-and-Guidance/Contraception-and-Breast-Cancer.aspx
    Show more Show less
    36 min
adbl_web_anon_alc_button_suppression_t1
No reviews yet